Skip to main content
SpringerLink
Log in
Book cover

Breast and Gynecological Cancers pp 125–148Cite as

Ovarian Cancer Screening and Early Detection in Low- and Middle-Income Countries

  • Chapter
  • First Online:

  • 1587 Accesses

Abstract

The burden of ovarian cancer worldwide and the rationale for and against screening are discussed. Sonography is very useful in identifying and triaging patients with adnexal masses who require surgical intervention. A detailed description of sonography in the characterization of adnexal masses is presented.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jemal A, Bray F, Center MM, et al. Global Cancer Statististics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Lyerly HK, Abernethy AP, Stockler MR, et al. Need for Global Partnership in Cancer Care: Perceptions of Cancer Care Researchers Attending the 2010 Australia and Asia Pacific Clinical Oncology Research Development Workshop. J Clin Oncol. 2011;7(5):324–9.

    Google Scholar 

  3. Yeole BB, Kumar AV, Kurkure A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev. 2004;5(3):308–15.

    PubMed  Google Scholar 

  4. Redaniel MTM, Laudico A, Mirasol-Lumague MR, Gondos A, GL U, Toral JA, Benavides, Brenner H. Ovarian cancer survival population differences: a “high-resolution study” comparing Philippine residents, and Filipino-Americans and Caucasians living in the US. BMC Cancer. 2009;9:340.

    Article  PubMed  Google Scholar 

  5. Van Nagell JR, Pavlik Jr EJ. Ovarian Cancer Screening. Clin Obstet Gynecol. 2012;55(1):43–51.

    Article  PubMed  Google Scholar 

  6. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Chronicle. Geneva: World Health Organization; 1968;22(11):473. Public health Papers #34.

    Google Scholar 

  7. Kurman RT, Shih I. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.

    Article  PubMed  Google Scholar 

  8. Crum CP, McKeon FD, Xian W. BRCA, the Oviduct, and the Space and Time Continuum of Pelvic Serous Carcinogenesis. Int J Gynecol Cancer. 2012;22:S29–34.

    Article  PubMed  Google Scholar 

  9. WHO Report. Task-shifting to tackle health worker shortages, March 2007 (http://www.who.int/healthsystems/task_shifting_booklet.pdf).

  10. Stormo AR, Cooper CP, Hawkins NA, Saraiya M. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med. 2012;54(6):415–21.

    Article  PubMed  Google Scholar 

  11. Smith EM, Anderson B. The effects of symptoms and delay in seeking diagnosis among women with cancers of the ovary. Cancer. 1985;56:2727–32.

    Article  PubMed  CAS  Google Scholar 

  12. Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1988;27:53–7.

    Article  PubMed  CAS  Google Scholar 

  13. Goff BA, Mandel L, Muntz HG, et al. Ovarian carcinoma diagnosis Cancer. 2000;89:2068–75.

    CAS  Google Scholar 

  14. Goff BA, Mandel LS, Melancon CH, et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291:2705–12.

    Article  PubMed  CAS  Google Scholar 

  15. Smith LH, Morris CR, Yasmeen S, et al. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer. 2005;104:1398–407.

    Article  PubMed  Google Scholar 

  16. Laurie G, Thompson PJ, McDuffie KE, et al. Prediagnostic symptoms of ovarian carcinoma: a case–control study. Gynecol Oncol. 2009;114:231–6.

    Article  Google Scholar 

  17. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221–7.

    Article  PubMed  Google Scholar 

  18. Rossing MA, Wicklund KG, Cushing-Haugen KL, et al. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst. 2010;102:222–9.

    Article  PubMed  Google Scholar 

  19. Goff BA, Lowe KA, Kane JC, et al. Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability. Gynecol Oncol. 2012;124:230–5.

    Article  PubMed  Google Scholar 

  20. Andersen MR, Goff BA, Lowe KA, et al. Combining a symptom index with CA125 to improve detection of ovarian cancer. Cancer. 2008;113:484–9.

    Article  PubMed  Google Scholar 

  21. Andersen MR, Goff BA, Lowe KA, et al. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2010;116:378–83.

    Article  PubMed  Google Scholar 

  22. Sassone AM, Timor-Tristsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78:70–6.

    PubMed  CAS  Google Scholar 

  23. Van Nagell JR, DePriest Jr PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol. 2000;77:350–6.

    Article  PubMed  Google Scholar 

  24. Van Nagell JR, DePriest Jr PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. 2007;109:1887–96.

    Article  PubMed  Google Scholar 

  25. Van Nagell JR, Jr MRW, DeSimone CP, et al. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011;118:1212–21.

    Article  PubMed  Google Scholar 

  26. Mol BV, Boll D, De Kanter M, et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol. 2001;80:162–7.

    Article  PubMed  CAS  Google Scholar 

  27. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10:327–40.

    Article  PubMed  Google Scholar 

  28. Menon U. The UKCTOCS Experience – Reasons for Hope? Int J Gynecol Cancer. 2012;22:S18–20.

    Article  PubMed  Google Scholar 

  29. Lagrone LN, Sadasivam V, Kushner AL, Groen RS. A review of training opportunities for ultrasonography in low and middle income countries. Trop Med Int Health. 2012;17:808–19.

    Article  PubMed  Google Scholar 

  30. Galukande M, Kiguli-Malwadde E. Rethinking breast cancer screening strategies in resource-limited settings. Afr Health Sci. 2010;10(1):89–92.

    PubMed  CAS  Google Scholar 

  31. Bast Jr RC, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883–7.

    Article  PubMed  Google Scholar 

  32. Jacobs I, Bast Jr RC. The CA125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989;4:1–12.

    Article  PubMed  CAS  Google Scholar 

  33. Mol BW, Bayram N, Lijmer JG, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril. 1998;70:1101–8.

    Article  PubMed  CAS  Google Scholar 

  34. Zuckerman E, Lanir A, Sabo E, et al. Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis. Am J Gastroenterol. 1999;94:1613–8.

    Article  PubMed  CAS  Google Scholar 

  35. Sjövall K, Nilsson B, Einhorn N. The significance of serum CA125 elevation in malignant and nonmalignant diseases. Gynecol Oncol. 2002;85:175–8.

    Article  PubMed  Google Scholar 

  36. Einhorn N, Sjövall K, Knapp RC, et al. Prospective evaluation of serum CA125 levels for early detection of ovarian cancer. Obstet Gynecol. 1992;80:14–8.

    PubMed  CAS  Google Scholar 

  37. Zurawski Jr VR, Orjaseter H, Andersen A, Jellum E. Elevated serum CA125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer. 1988;42:677–80.

    Article  PubMed  Google Scholar 

  38. Jacobs I, Davies AP. BridgesJ et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ. 1993;306:1030–4.

    Article  PubMed  CAS  Google Scholar 

  39. Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randoized Controlled Trial. JAMA. 2011;305:2295–303.

    Article  PubMed  CAS  Google Scholar 

  40. Buys SS, Partridge E, Greene MH, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193:1630–9.

    Article  PubMed  Google Scholar 

  41. Skates SJ. Ovarian cancer screening: development of the Risk of Ovarian Cancer Algorithm (ROCA) and ROCA Screening Trials. Int J Gynecol Cancer. 2012;22:S24–6.

    Article  PubMed  Google Scholar 

  42. Skates SJ, Xu FJ, Yu YH, et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer. 1995;76:2004–10.

    Article  PubMed  CAS  Google Scholar 

  43. Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18:414–20.

    Article  PubMed  CAS  Google Scholar 

  44. Jacobs I, Davies AP, Bridges J, et al. Prevalence screening for ovarian cancer in postmenopausal women by CA125 measurement and ultrasonography. BMJ. 1993;306:1030–4.

    Article  PubMed  CAS  Google Scholar 

  45. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomized controlled trial. Lancet. 1999;353:1207–10.

    Article  PubMed  CAS  Google Scholar 

  46. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case–control studies. Am J Epidemiol. 1992;136:1184–203.

    PubMed  CAS  Google Scholar 

  47. Adami HO, Hsie CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet. 1994;344:1250–4.

    Article  PubMed  CAS  Google Scholar 

  48. Nandakumar A, Anantha N, Dhar M, et al. A case–control investigation on cancer of the ovary in Bangalore, India. Int J Cancer. 1995;63(3):361–5.

    Article  PubMed  CAS  Google Scholar 

  49. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer: A prospective study. JAMA. 1993;270:2813–8.

    Article  PubMed  CAS  Google Scholar 

  50. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol. 1991;134:362–9.

    PubMed  CAS  Google Scholar 

  51. Rosenblatt KA, Thomas DB. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996;5:933–5.

    PubMed  CAS  Google Scholar 

  52. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med. 1987;316:650–5.

    Article  Google Scholar 

  53. Consensus NIH. Conference. Ovarian cancer: screening, treatment, and follow-up—NIH Consensus Development Panel on Ovarian Cancer. JAMA. 1995;273:491–7.

    Article  Google Scholar 

  54. Timmerman D, Schwartzberg P, Collins WP, et al. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol. 1999;13:11–6.

    Article  PubMed  CAS  Google Scholar 

  55. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelest H, Vergote I. Terms definitions and measurements to describe the sonographic features of adnexal tumors. A consensus opinion from the International Ovarian Tumor Analysis [IOTA] Group. Ultrasound Obstet Gynecol. 2000;16:500–5.

    Article  PubMed  CAS  Google Scholar 

  56. Timmerman D, Testa AC, Bourne TH. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005;23:8794–801.

    Article  PubMed  Google Scholar 

  57. Holsbeke CV, Calster BV, Testa AC. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study. Clin Cancer Res. 2009;15(2):684–91.

    Article  PubMed  Google Scholar 

  58. Valentin L, Ameye L, Savelli L, Fruscio R, Leone FPG, Czekierdowski A, et al. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol. 2011;38:456–65.

    Article  PubMed  CAS  Google Scholar 

  59. Amor F, Vaccaro H, Alcazar JL, Leon M, Craig JM, Martinez J. Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings. J Ultrasound Med. 2009;28:285–91.

    PubMed  Google Scholar 

  60. Amor F, Alcázar JL, Vaccaro H, León M, Iturra A. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol. 2011;38:450–5.

    Article  PubMed  CAS  Google Scholar 

  61. Twickler DM, Moschos E. Ultrasound and assessment of ovarian cancer risk. AJR Am J Roentgenol. 2010;194:322–9.

    Article  PubMed  Google Scholar 

  62. Jeong YY, Outwater EK, Kang HK. Imaging Evaluation of Ovarian Masses. Radiographics. 2000;20:1445–70.

    PubMed  CAS  Google Scholar 

  63. Reles A, Wein U, Lichtenegger W. Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses. J Clin Ultrasound. 1997;25:217–25.

    Article  PubMed  CAS  Google Scholar 

  64. Timor-Tritsch LE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol. 1993;168:909–13.

    PubMed  CAS  Google Scholar 

  65. Patel MD. Pitfalls in the sonographic evaluation of adnexal masses. Ultrasound Q. 2012;28(1):29–40.

    Article  PubMed  Google Scholar 

  66. Levine D, Brown DL, Andreotti RF, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology. 2010;256:943–54.

    Article  PubMed  Google Scholar 

  67. Tyagi SP, Maheswari V, Tyagi N, et al. Solid tumors of the ovary. J Ind Med Assoc. 1993;91(9):227–30.

    CAS  Google Scholar 

  68. Dierickx I, Valentin L, Holsbeke C, et al. Imaging in Gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary. Ultrasound Obstet Gynecol. 2012;40(6):706–13. doi:10.1002/uog.11149 [Epub ahead of print].

    Article  PubMed  CAS  Google Scholar 

  69. Wang S, Johnson S. Prediction of benignity of solid adnexal masses. Arch Gynecol Obstet. 2012;285(3):721–6.

    Article  PubMed  Google Scholar 

  70. Jung SE, Rha SE, Lee JM, et al. CT and MRI Findings of Sex Cord–Stromal Tumor of the Ovary. AJR. 2005;185:207–15.

    Article  PubMed  Google Scholar 

  71. Yazbek J, Raju KS, Ben-Nagi J, et al. Accuracy of ultrasound subjective ‘pattern recognition’ for the diagnosis of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2007;29:489–95.

    Article  PubMed  CAS  Google Scholar 

  72. Vergote I, Tropé CG, Amant FN, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363(10):943–53.

    Article  PubMed  CAS  Google Scholar 

  73. Sterling L, van Lonkhuijzen L, Nyangena J, Orango E, Strother M, Busakhala N, Rosen B. Protocol development for ovarian cancer treatment in Kenya: a brief report. Int J Gynecol Cancer. 2011;21(2):424–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Women and Infants’ Hospital, Providence, RI, 02905, USA

    Trevor Tejada-Bergés

  2. Department of Health and Human Services, Center for Global Health, National Cancer Institute, National Institutes of Health, Rockville, MD, 20852, USA

    Edward L. Trimble

  3. Woman’s Center for Breast Care and MRI, Woman’s Hospital of Texas, Houston, TX, 77054, USA

    Mahesh K. Shetty

Authors
  1. Trevor Tejada-Bergés
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward L. Trimble
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahesh K. Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trevor Tejada-Bergés .

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, Baylor Plaza 1, Houston, 77030, Texas, USA

    Mahesh K. Shetty

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tejada-Bergés, T., Trimble, E.L., Shetty, M.K. (2013). Ovarian Cancer Screening and Early Detection in Low- and Middle-Income Countries. In: Shetty, M. (eds) Breast and Gynecological Cancers. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1876-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1876-4_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1875-7

  • Online ISBN: 978-1-4614-1876-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation